LB2303 - Single High-dose of Liposomal Amphotericin B in HIV/AIDS-related Disseminated Histoplasmosis: a Randomized Trial

Presenting Author(s)

• 

  Alessandro C. Pasqualotto, FECMM (he/him/his)

  Professor of Infectious Diseases
  Universidade Federal de Ciencias da Saude de Porto Alegre
  Porto Alegre, Rio Grande do Sul, Brazil

  Disclosure: Disclosure(s): Gilead: Grant/Research Support (); United Medical: Advisor/Consultant (), Honoraria ()

  Slides

Co-Author(s)

• CG

  Cassia M. Godoy, MD

  Hospital de Doencas Tropicais
  Goiania, Goias, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• DD

  Daiane Dalla Lana, PhD

  Universidade Federal de Ciencias da Saude de Porto Alegre
  Porto Alegre, Rio Grande do Sul, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• TL

  Terezinha S. Leitao, MD

  Universidade Federal do Ceara
  Fortaleza, Ceara, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• MB

  Monica B. Bay, MD

  Universidade Federal do Rio Grande do Norte
  Natal, Rio Grande do Norte, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• LD

  Lisandra S. Damasceno, MD

  Hospital Sao Jose
  Fortaleza, Ceara, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• RS

  Renata B. Soares, PhD

  PUC de Goias
  Goiania, Goias, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• DF

  Diego R. Falci, MD

  PUCRS
  Porto Alegre, Rio Grande do Sul, Brazil

  Disclosure: Disclosure(s): United Medical: Advisor/Consultant (), Honoraria ()
• RK

  Roger Kist, PharmD

  Santa Casa de Misericordia de Porto Alegre
  Porto Alegre, Rio Grande do Sul, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• LS

  Larissa R. Silva, BsC

  Universidade Federal de Ciencias da Saude de Porto Alegre
  Porto Alegre, Rio Grande do Sul, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• MM

  Marineide Melo, MD

  Hospital Nossa Senhora da Conceicao
  Porto Alegre, Rio Grande do Sul, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• TG

  Taiguara F. Guimaraes, MD

  Hospital de Doencas Tropicais
  Goiania, Goias, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• MG

  Marilia R. Guimaraes, MD

  Hospital de Doencas Tropicais
  Goiania, Goias, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• HV

  Hareton T. Vechi, MD

  Universidade Federal do Rio Grande do Norte
  Natal, Rio Grande do Norte, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• JM

  Jaco Mesquita, MD

  Hospital Sao Jose
  Fortaleza, Ceara, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• EM

  Erianna Y. Macedo, MD

  Hospital Sao Jose
  Fortaleza, Ceara, Brazil

  Disclosure: Disclosure(s): No financial relationships to disclose
• AA

  Antoine A. Adenis, MD

  Centre d'Investigation Clinique Antilles-Guyane
  Cayenne, French Guiana

  Disclosure: Disclosure(s): No financial relationships to disclose
• NB

  Nathan C. Bahr, MD

  University of Kansas
  Kansas City, Kansas, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• 

  Andrej Spec, MD, MSCI

  Assistant Professor
  Washington University in St. Louis
  St. Louis, Missouri, United States

  Disclosure: Disclosure(s): Astellas: Grant/Research Support ()
• 

  David R. Boulware, MD, MPH, CTropMed

  Professor
  University of Minnesota
  Minneapolis, Minnesota, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• DI

  Dennis Israelski, MD

  Gilead Sciences
  San Francisco, California, United States

  Disclosure: Disclosure(s): Gilead Sciences: Empoyee ()
• 

  Tom M. Chiller, MD

  Chief, Mycotic Diseases Branch
  Centers for Disease Control and Prevention
  Atlanta, Georgia, United States

  Disclosure: Disclosure(s): No financial relationships to disclose